- Home
- Program Information
- Key Dates
- Committees
- Submit Abstracts
- Submit Papers
- Submit Posters
- Registration
- Logistics
- Related Meetings
- Mailing List
PROGRAM INFORMATION
- Suggested arrival and check-in time at the registration desk is Tuesday September 18, 10:30-11:15 a.m.
- The first talk is Tuesday 11:15 a.m. This is a joint session with RECOMB-CG.
- Lunch (12:30-2:00) is open to participants in both meetings.
- RECOMB-CG participants will depart at lunch and the first talk for RECOMB-CCB only will be at 2:00 p.m.
- On Thursday September 20, the last talk ends at 12:30 p.m., followed by lunch.
Download
[Program] [Abstracts] [Poster list] [Flyer]
 |
Donna G. Albertson (University of California, San Francisco) |
 |
Anne-Lise Børresen-Dale (Institute for Cancer Research, Norwegian Radium Hospital) |
 |
Colin Collins (University of California, San Francisco) |
 |
Paul Meltzer (National Cancer Institute) |
 |
Paul Spellman (Lawrence Berkeley National Labs) |
 |
Barbara J. Trask (Fred Hutchinson Cancer Research Center) |
 |
Rick Wilson (Washington University, St. Louis) |
CONTRIBUTED PAPERS
Bhaskar DasGupta, Jin Jun and Ion Mandoiu. Primer Selection Methods for Detection of Genomic Inversions and Deletions via PAMP.
Kartik Mani, Celine Lefebvre, Kai Wang, Wei Keat Lim, Katia Basso, Riccardo Dalla-Favera and Andrea Califano. A Systems Biology Approach to the Identification of Causal Somatic Mechanisms in Cancer Phenotypes.
Michal Ozery-Flato and Ron Shamir. On the frequency of genome rearrangement events in cancer karyotypes.
Anya Tsalenko, Roy Navon, Israel Steinfeld, Hui Wang, Robert Ach, Bo Curry, Laurakay Bruhn, Amir Ben-Dor and Zohar Yakhini. Analyzing Matched Differential Gene Expression with an Application to Cancer vs. Normal MicroRNA Data.
Gennady Verkhivker. Computational structural proteomics of protein interactions determines specificity signatures of cancer drugs.
CONTRIBUTED ABSTRACTS (partial list)Greg Finak, Morag Park and Michael Hallett. Variance Component Estimation for Class Discovery and Class Distinction in Microarray Data.
Anna Lapuk, Miki Yamamoto, John Conboy, Ken Simpson, Elizabeth Purdom, Terry Speed, Hovig Bayandorian, Rich Neve, Tyson A. Clark, John E. Blume and Joe W Gray. Alternative splicing in breast cancer cell lines: whole-genome detection of cell specific isoforms using novel method FIRMA.
Hojoon Lee and Stephen Johnston. Identification of tumor-specific mutations in coding microsatellite DNAs by using EST data.
Jimmy Lin and Victor Velculescu. A multi-dimensional analysis of genes mutated in breast and colorectal cancers.
Christiaan Klijn, Henne Holstege, Jeroen de Ridder, Xiaoling Liu, Marcel J.T. Reinders, Jos Jonkers and Lodewyk Wessels. Statistical multi-experiment analysis of non-discretized array CGH data.
Michael Kreutzer, Larisa Kiseleva, Gilbert Schoenfelder, Marcus Haemmerle, Stephan Stoerkel and Hans-Juergen Thiesen. Initial steps of in-silico-subtyping of human tumour tissues as exemplified on toponome profiles characterizing individual renal clear cell carcinomas (RCC).
Eric Scheeff, Erin Pleasance, Yufeng Zhai, Patrick Schacht, Michael Dacre, Ali Torkamani, Nicholas Schork, Andrew Futreal and Gerard Manning. Predicting the functional impact of somatic mutations in protein kinases using evolutionary constraints.
Bahar Taneri and Terry Gaasterland. Nova Regulated Aberrant Alternative Splicing in Cancer Tissues.
Ali Torkamani and Nicholas Schork. Prediction of Somatic Cancer Driver Mutations in Protein Kinases.
Stanislav Volik, Benjamin Raphael, Peng Yu, Chunxiao Wu, Guiqing Huang, Yasuko Kobayashi, Pamela Paris, Joe Gray, Jan-Fang Chen, Pieter de Jong and Hesed Padilla-Nash. The possibility of personalized oncology using ESP combined with next generation technology.
Further details to be announced, including additional talks, contributed abstracts, poster abstracts, and
the program schedule.